The present application provides: a composition for improvement of QOL including improvement, suppression or reduction of at least one symptom attributed to cancer selected from the group consisting of cancerous pain, decreased appetite, insomnia, physical fatigue, and poor complexion or coloring in a subject, the composition being characterized by comprising molecular hydrogen as an effective ingredient； and a method for improving QOL in a subject with cancer, comprising administering the composition to the subject.
